ℹ️ Compiled from public regulatory records · Last regulator revision: May 19, 2026🚩 Report this page

Ocrelizumab

Monoclonal Antibodies

Sold as Ocrevus

GB MHRAEU EMACA Health Canada

Drug class: Monoclonal Antibodies
Availability: See label
Routes: Intravenous
Markets covered: 3
Products on record: 5

Overview

Ocrelizumab is an active pharmaceutical ingredient in the Monoclonal Antibodies group (L04AG). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	3	May 1, 2026
EU European Union	EMA	1	April 16, 2026
CA Canada	Health Canada	1	May 19, 2026

GBUnited Kingdom· MHRA

3 products

Uses

GBOfficial regulatory label· revised May 1, 2026[1]

1). 1).

How to take

GBOfficial regulatory label· revised May 1, 2026

EUEuropean Union· EMA

1 product

Uses

EUOfficial regulatory label· revised April 16, 2026[2]

1). 1).

How to take

EUOfficial regulatory label· revised April 16, 2026

CACanada· Health Canada

1 product

1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].

Brands in Canada (1)

OCREVUSHOFFMANN-LA ROCHE LIMITED

Drug interactions

Known interactions involving Ocrelizumab. Select one for details. This list is informational and not a complete interaction checker.

Adalimumab Baricitinib Certolizumab Pegol Cladribine Etanercept Fingolimod Golimumab Infliximab Leflunomide Natalizumab Ozanimod Siponimod Teriflunomide Tofacitinib Upadacitinib Abatacept Abemaciclib Acalabrutinib Acetohydroxamic Acid Aflibercept Albendazole Aldesleukin Alefacept Alemtuzumab Altretamine Anakinra Antilymphocyte Immunoglobulin Asparaginase Atezolizumab Auranofin Aurothioglucose Avapritinib Axicabtagene Ciloleucel Azacitidine Azathioprine Basiliximab Belantamab Mafodotin Belatacept Belimumab Belinostat Bendamustine Betamethasone Bexarotene Bleomycin Blinatumomab Bortezomib Bosutinib Brentuximab Vedotin Brexucabtagene Autoleucel Brigatinib Brodalumab Budesonide Busulfan Cabazitaxel Canakinumab Candida Albicans Capecitabine Carbamazepine Carboplatin Carfilzomib Carmustine Chlorambucil Chloramphenicol Cisplatin Clofarabine Cobimetinib Coccidioides Immitis Spherule Colchicine Copanlisib Corticotropin Cosyntropin Cyclophosphamide Cyclosporine Cytarabine Dacarbazine Dactinomycin Dapsone Daratumumab Dasatinib Daunorubicin Decitabine Deflazacort Denileukin Diftitox Denosumab Dexamethasone Dimethyl Fumarate Dinutuximab Diroximel Fumarate Docetaxel Doxorubicin Durvalumab Duvelisib Efalizumab Elotuzumab Epirubicin Eribulin Ethotoin Etoposide Everolimus Felbamate Floxuridine Flucytosine Fludarabine Fludrocortisone Fluorouracil Gemcitabine Gemtuzumab Ozogamicin Guanidine Guselkumab Hydrocortisone Hydroxyurea Ibritumomab Tiuxetan Ibrutinib Idarubicin Idelalisib Ifosfamide Imatinib Inebilizumab Inotuzumab Ozogamicin Interferon Alfa-2b Interferon Alfa-N1 Interferon Alfa-N3 Interferon Alfacon-1 Interferon Gamma-1b Irinotecan Isatuximab Ixabepilone Ixazomib Ixekizumab Lactobacillus Acidophilus Lenalidomide Levamisole Linezolid Lisocabtagene Maraleucel Lomustine Lurbinectedin Mechlorethamine Melphalan Mephenytoin Mercaptopurine Methotrexate Methylprednisolone Midostaurin Mitomycin Mitoxantrone Mogamulizumab Monomethyl Fumarate Mycophenolate Mofetil Mycophenolic Acid Naxitamab Nelarabine Nilotinib Niraparib Obinutuzumab Ofatumumab Olaparib Olaratumab Omacetaxine Mepesuccinate Osimertinib Oxaliplatin Paclitaxel Palbociclib Panobinostat Paramethadione Pazopanib Peginterferon Alfa-2a Peginterferon Alfa-2b Pemetrexed Penicillamine Pentamidine Pentostatin Phenylbutazone Plicamycin Polatuzumab Vedotin Pomalidomide Ponatinib Pralatrexate Prednisolone Prednisone Primaquine Procainamide Procarbazine Ribociclib Rilonacept Risankizumab Rituximab Roflumilast Romidepsin Rucaparib Ruxolitinib Sarilumab Satralizumab Secukinumab Selinexor Siltuximab Sipuleucel-T Sirolimus Streptozocin Tacrolimus Tafasitamab Talazoparib Temozolomide Temsirolimus Teniposide Thalidomide Thioguanine Thiotepa Tildrakizumab Tisagenlecleucel Tocainide Tocilizumab Topotecan Tositumomab Trabectedin Trastuzumab Triamcinolone Trifluridine Trimethadione Trimetrexate Uracil Mustard Ustekinumab Vedolizumab Venetoclax Vibrio Cholerae CVD 103-HGR Strain Live Antigen Vinblastine Vincristine Vinorelbine Zanubrutinib Zidovudine Vitamin E Zinc Acetate Zinc Chloride Zinc Gluconate Zinc Sulfate

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]MHRA (UK) · PLGB000310889 · revised May 1, 2026
[2]European Medicines Agency · EMEA/H/C/004043 · revised April 16, 2026
[3]Health Canada (DPD) · 02467224 · revised May 19, 2026

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.